Empress Therapeutics is to generate transformative drug candidates that get to the clinic faster and cheaper.
Empress Therapeutics has raised $50.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2023.
Empress Therapeutics's investors include Flagship Pioneering.
Empress Therapeutics is headquartered in Cambridge, United States.
Empress Therapeutics is to generate transformative drug candidates that get to the clinic faster and cheaper.
Empress Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Empress Therapeutics — Funding & Investors." VCBacked, June 21, 2023, https://www.vcbacked.co/company/empress-therapeutics. Accessed November 11, 2026.
VCBacked. (2023). Empress Therapeutics — Funding & Investors. Retrieved November 11, 2026, from https://www.vcbacked.co/company/empress-therapeutics
{{cite web |title=Empress Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/empress-therapeutics |website=VCBacked |access-date=November 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Empress Therapeutics? Request a listing update